Suvorexant and its Impurities

Suvorexant is used to treat insomnia. Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia.Reference standards of Suvorexant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 27 results for Suvorexant Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 46 49000

Suvorexant

Suvorexant


  • Catalogue No.:PA 46 49000

  • CAS :

    1030377-33-3

  • Molecular Formula : C23H23ClN6O2

  • Molecular Weight : 450.93

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491000

Benzyl (S)-5-methyl-1,4-diazepane-1-carboxylate

Benzyl (S)-5-methyl-1,4-diazepane-1-carboxylate


  • Catalogue No.:PA 46 0491000

  • CAS :

    1001401-61-1

  • Molecular Formula : C14H20N2O2

  • Molecular Weight : 248.33

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491001

(R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole

(R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole


  • Catalogue No.:PA 46 0491001

  • CAS :

    1266975-27-2

  • Molecular Formula : C13H16ClN3O

  • Molecular Weight : 265.74

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491002

(5R)-1-(5-Chloro-3-hydroxy-2,3-dihydrobenzo[d]oxazol-2-yl)-5-methyl-4-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,4-diazepane 1-oxide

(5R)-1-(5-Chloro-3-hydroxy-2,3-dihydrobenzo[d]oxazol-2-yl)-5-methyl-4-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,4-diazepane 1-oxide


  • Catalogue No.:PA 46 0491002

  • CAS :

    NA

  • Molecular Formula : C23H25ClN6O4

  • Molecular Weight : 484.94

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491003

((7R)-4-(5-Chloro-2-hydroxy-2,3-dihydrobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

((7R)-4-(5-Chloro-2-hydroxy-2,3-dihydrobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone


  • Catalogue No.:PA 46 0491003

  • CAS :

    NA

  • Molecular Formula : C23H25ClN6O3

  • Molecular Weight : 468.94

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491004

(R)-5-Chloro-2-(5-methyl-4-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,4-diazepan-1-yl)benzo[d]oxazole 3-oxide

(R)-5-Chloro-2-(5-methyl-4-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,4-diazepan-1-yl)benzo[d]oxazole 3-oxide


  • Catalogue No.:PA 46 0491004

  • CAS :

    NA

  • Molecular Formula : C23H23ClN6O3

  • Molecular Weight : 466.93

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491005

(R)-2-(2-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepane-1-carbonyl)-4-methylphenyl)-2H-1,2,3-triazole 1,3-dioxide

(R)-2-(2-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepane-1-carbonyl)-4-methylphenyl)-2H-1,2,3-triazole 1,3-dioxide


  • Catalogue No.:PA 46 0491005

  • CAS :

    NA

  • Molecular Formula : C23H23ClN6O4

  • Molecular Weight : 482.93

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491006

(R)-(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(7-methyl-4-nitroso-1,4-diazepan-1-yl)methanone

(R)-(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(7-methyl-4-nitroso-1,4-diazepan-1-yl)methanone


  • Catalogue No.:PA 46 0491006

  • CAS :

    NA

  • Molecular Formula : C16H20N6O2

  • Molecular Weight : 328.38

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491007

(R)-1-Benzyl-5-methyl-4-nitroso-1,4-diazepane

(R)-1-Benzyl-5-methyl-4-nitroso-1,4-diazepane


  • Catalogue No.:PA 46 0491007

  • CAS :

    NA

  • Molecular Formula : C13H19N3O

  • Molecular Weight : 233.32

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491008

(R)-(7-Methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

(R)-(7-Methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone


  • Catalogue No.:PA 46 0491008

  • CAS :

    1030377-32-2

  • Molecular Formula : C16H21N5O

  • Molecular Weight : 299.38

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491009

(R)-(4-Benzyl-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

(R)-(4-Benzyl-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone


  • Catalogue No.:PA 46 0491009

  • CAS :

    1620097-07-5

  • Molecular Formula : C23H27N5O

  • Molecular Weight : 389.5

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491010

(R)-1-Benzyl-5-methyl-1,4-diazepane

(R)-1-Benzyl-5-methyl-1,4-diazepane


  • Catalogue No.:PA 46 0491010

  • CAS :

    1620097-06-4

  • Molecular Formula : C13H20N2

  • Molecular Weight : 204.32

Drug Reference Standards & Impurity Synthesis in India
PA STI 089669

Suvorexant-D2

Suvorexant-D2


  • Catalogue No.:PA STI 089669

  • CAS :

    2766580-44-1

  • Molecular Formula : C23H21D2ClN6O2

  • Molecular Weight : 452.94

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491011

(R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-(hydroxymethyl)-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

(R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-(hydroxymethyl)-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone


  • Catalogue No.:PA 46 0491011

  • CAS :

    1030377-39-9

  • Molecular Formula : C23H23ClN6O3

  • Molecular Weight : 466.93

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491012

Suvorexant S-Isomer

Suvorexant S-Isomer


  • Catalogue No.:PA 46 0491012

  • CAS :

    1030377-80-0

  • Molecular Formula : C23H23ClN6O2

  • Molecular Weight : 450.93

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491013

(S)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole

(S)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole


  • Catalogue No.:PA 46 0491013

  • CAS :

    1276666-15-9

  • Molecular Formula : C13H16ClN3O

  • Molecular Weight : 265.74

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491014

(R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-5-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

(R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-5-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone


  • Catalogue No.:PA 46 0491014

  • CAS :

    1276666-19-3

  • Molecular Formula : C23H23ClN6O2

  • Molecular Weight : 450.93

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491015

2-Iodo-5-methylbenzoic Acid

2-Iodo-5-methylbenzoic Acid


  • Catalogue No.:PA 46 0491015

  • CAS :

    52548-14-8

  • Molecular Formula : C8H7IO2

  • Molecular Weight : 262.05

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491016

5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl Chloride

5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl Chloride


  • Catalogue No.:PA 46 0491016

  • CAS :

    1104546-96-4

  • Molecular Formula : C10H8ClN3O

  • Molecular Weight : 221.64

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491017

2-Nitroso-2H-1,2,3-triazole

2-Nitroso-2H-1,2,3-triazole


  • Catalogue No.:PA 46 0491017

  • CAS :

    NA

  • Molecular Formula : C2H2N4O

  • Molecular Weight : 98.07

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491018

(R)-5-Methyl-1-nitroso-1,4-diazepane

(R)-5-Methyl-1-nitroso-1,4-diazepane


  • Catalogue No.:PA 46 0491018

  • CAS :

    NA

  • Molecular Formula : C6H13N3O

  • Molecular Weight : 143.19

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491019

(R)-7-Methyl-1-nitroso-1,4-diazepane

(R)-7-Methyl-1-nitroso-1,4-diazepane


  • Catalogue No.:PA 46 0491019

  • CAS :

    NA

  • Molecular Formula : C6H13N3O

  • Molecular Weight : 143.19

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491020

(R)-7-Methyl-1-nitroso-1,4-diazepane

(R)-5-Methyl-1,4-dinitroso-1,4-diazepane


  • Catalogue No.:PA 46 0491020

  • CAS :

    NA

  • Molecular Formula : C6H12N4O2

  • Molecular Weight : 172.19

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491021

5-Chlorobenzoxazole

5-Chlorobenzoxazole


  • Catalogue No.:PA 46 0491021

  • CAS :

    17200-29-2

  • Molecular Formula : C7H4ClNO

  • Molecular Weight : 153.57

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491022

2-(2-Aminoethyl)isoindoline-1,3-dione

2-(2-Aminoethyl)isoindoline-1,3-dione


  • Catalogue No.:PA 46 0491022

  • CAS :

    71824-24-3

  • Molecular Formula : C10H10N2O2

  • Molecular Weight : 190.2

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491023

[2,2'-Biisoindoline]-1,1',3,3'-tetraone

[2,2'-Biisoindoline]-1,1',3,3'-tetraone


  • Catalogue No.:PA 46 0491023

  • CAS :

    4388-29-8

  • Molecular Formula : C16H8N2O4

  • Molecular Weight : 292.25

Drug Reference Standards & Impurity Synthesis in India
PA 46 0491024

2,2'-(Oxybis(ethane-2,1-diyl))bis(isoindoline-1,3-dione)

2,2'-(Oxybis(ethane-2,1-diyl))bis(isoindoline-1,3-dione)


  • Catalogue No.:PA 46 0491024

  • CAS :

    43113-25-3

  • Molecular Formula : C20H16N2O5

  • Molecular Weight : 364.36

pharmaffiliates